Cargando…
Syphilis Predicts HIV Incidence Among Men and Transgender Women Who Have Sex With Men in a Preexposure Prophylaxis Trial
Background. Syphilis infection may potentiate transmission of human immunodeficiency virus (HIV). We sought to determine the extent to which HIV acquisition was associated with syphilis infection within an HIV preexposure prophylaxis (PrEP) trial and whether emtricitabine/tenofovir (FTC/TDF) modifie...
Autores principales: | Solomon, Marc M., Mayer, Kenneth H., Glidden, David V., Liu, Albert Y., McMahan, Vanessa M., Guanira, Juan V., Chariyalertsak, Suwat, Fernandez, Telmo, Grant, Robert M., Bekker, Linda-Gail, Buchbinder, Susan, Casapia, Martin, Guanira, Juan, Kallas, Esper, Lama, Javier, Mayer, Kenneth, Montoya, Orlando, Schechter, Mauro, Veloso, Valdiléa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166980/ https://www.ncbi.nlm.nih.gov/pubmed/24928295 http://dx.doi.org/10.1093/cid/ciu450 |
Ejemplares similares
-
HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial
por: Deutsch, Madeline B., et al.
Publicado: (2015) -
Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors
por: Janes, Holly, et al.
Publicado: (2019) -
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
por: Solomon, Marc M., et al.
Publicado: (2014) -
Daily Oral Emtricitabine/Tenofovir Preexposure Prophylaxis and Herpes Simplex Virus Type 2 among Men Who Have Sex with Men
por: Marcus, Julia L., et al.
Publicado: (2014) -
The Safety of Tenofovir–Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
por: Solomon, Marc M., et al.
Publicado: (2016)